V-Region Gene Analysis of Locally Defined Synovial B and Plasma Cells Reveals Selected B Cell Expansion and Accumulation of Plasma Cell Clones in Rheumatoid Arthritis

被引:74
作者
Scheel, Tobias [1 ]
Gursche, Angelika [2 ]
Zacher, Josef [2 ]
Haeupl, Thomas [3 ]
Berek, Claudia [1 ]
机构
[1] Deutsch Rheuma Forschungszentrum, D-10117 Berlin, Germany
[2] Helios Kliniken Berlin Buch, Berlin, Germany
[3] Charite, D-13353 Berlin, Germany
来源
ARTHRITIS AND RHEUMATISM | 2011年 / 63卷 / 01期
关键词
GERMINAL-CENTERS; SOMATIC HYPERMUTATION; DOUBLE-BLIND; TISSUE; LYMPHOCYTE; RITUXIMAB; POPULATIONS; MEMBRANE; EFFICACY; IDENTIFICATION;
D O I
10.1002/art.27767
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To elucidate the development of synovial tissue-specific B cell immune responses, the clonality of individual naive B cells, memory B cells, and plasma cells and their organization and histologic localization in the inflamed tissue were investigated in patients with rheumatoid arthritis (RA). Methods. B and plasma cells were isolated by laser capture microdissection (LCM) from the synovial tissue of patients with RA. In addition, single naive B cells, memory B cells, and plasma cells were sorted from synovial tissue cell suspensions. RNA was extracted from the cells, and Ig V-H genes were amplified, cloned, and sequenced. Results. Both LCM and single cell sorting analyses showed that naive and memory B cells infiltrated the RA synovial tissue. Comparison of the V-gene repertoire of B and plasma cells suggested that synovial plasma cells were generated, by and large, from locally activated B cells, indicating that a selected population of memory B cells differentiates into large plasma cell clones that then accumulate in the inflamed tissue. Clonally related plasma cells were isolated from separate and distinct localized areas of the tissue, suggesting that the newly generated plasma cells have a high migratory capacity. Conclusion. These results support the idea of a continuous activation of selected B cell clones, and hence a massive accumulation of plasma cells, in RA synovial tissue. As B cells and their secreted antibodies are an important factor in controlling inflammatory processes, patients with RA displaying intensive synovial tissue lymphocytic infiltrations might benefit from B cell depletion therapy. Early treatment will prevent accumulation of pathogenic plasma cells.
引用
收藏
页码:63 / 72
页数:10
相关论文
共 35 条
[1]   THE AMERICAN-RHEUMATISM-ASSOCIATION 1987 REVISED CRITERIA FOR THE CLASSIFICATION OF RHEUMATOID-ARTHRITIS [J].
ARNETT, FC ;
EDWORTHY, SM ;
BLOCH, DA ;
MCSHANE, DJ ;
FRIES, JF ;
COOPER, NS ;
HEALEY, LA ;
KAPLAN, SR ;
LIANG, MH ;
LUTHRA, HS ;
MEDSGER, TA ;
MITCHELL, DM ;
NEUSTADT, DH ;
PINALS, RS ;
SCHALLER, JG ;
SHARP, JT ;
WILDER, RL ;
HUNDER, GG .
ARTHRITIS AND RHEUMATISM, 1988, 31 (03) :315-324
[2]   Distinction of the memory B cell response to cognate antigen versus bystander inflammatory signals [J].
Benson, Micah J. ;
Elgueta, Raul ;
Schpero, William ;
Molloy, Michael ;
Zhang, Weijun ;
Usherwood, Edward ;
Noelle, Randolph J. .
JOURNAL OF EXPERIMENTAL MEDICINE, 2009, 206 (09) :2013-2025
[3]   Analysis of the human V-H gene repertoire - Differential effects of selection and somatic hypermutation on human peripheral CD5(+)/IgM(+) and CD5(-)/IgM(+) B cells [J].
Brezinschek, HP ;
Foster, SJ ;
Brezinschek, RI ;
Dorner, T ;
DomiatiSaad, R ;
Lipsky, PE .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (10) :2488-2501
[4]  
BRIDGES SL, 1993, ARTHRITIS RHEUM, V36, P631
[5]  
Chaiamnuay Sumapa, 2005, Pathophysiology, V12, P203, DOI 10.1016/j.pathophys.2005.07.007
[6]   Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy - Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks [J].
Cohen, Stanley B. ;
Emery, Paul ;
Greenwald, Maria W. ;
Dougados, Maxime ;
Furie, Richard A. ;
Genovese, Mark C. ;
Keystone, Edward C. ;
Loveless, James E. ;
Burmester, Gerd-Ruediger ;
Cravets, Matthew W. ;
Hessey, Eva W. ;
Shaw, Timothy ;
Totoritis, Mark C. .
ARTHRITIS AND RHEUMATISM, 2006, 54 (09) :2793-2806
[7]  
DUKE O, 1982, CLIN EXP IMMUNOL, V49, P22
[8]   Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis [J].
Edwards, JCW ;
Szczepanski, L ;
Szechinski, J ;
Filipowicz-Sosnowska, A ;
Emery, P ;
Close, DR ;
Stevens, RM ;
Shaw, T .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (25) :2572-2581
[9]   The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment - Results of a phase IIb randomized, double-blind, placebo-controlled, dose-ranging trial [J].
Emery, P ;
Fleischmann, R ;
Filipowicz-Sosnowska, A ;
Schechtman, J ;
Szczepanski, L ;
Kavanaugh, A ;
Racewicz, AJ ;
Van Vollenhoven, RF ;
Li, NF ;
Agarwal, S ;
Hessey, EW ;
Shaw, TM .
ARTHRITIS AND RHEUMATISM, 2006, 54 (05) :1390-1400
[10]  
FRENCH M, 1986, MONOGR ALLERGY, V19, P100